Alendronate
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6573 publications
Weekly treatment with oral alendronate maintains bone mineral increases gained after one year of romosozumab treatment, in women with chronic spinal cord injury.
Journal: The journal of spinal cord medicine
Published: January 14, 2026
Bone-Targeted Multifunctional Nanoplatform Combining Osteoimmunoregulation and Mild Photothermal Effect to Promote Fracture Repair.
Journal: ACS nano
Published: December 30, 2025
Bone-Targeted Platinum Nanoframework Prevents Postmenopausal Osteoporosis via Transmembrane Protein 16A Channel Blockade and Reactive Oxygen Species Scavenging.
Journal: ACS nano
Published: December 27, 2025
P19 A rare case of PHOAR2-enteropathy syndrome (PHOAR2E; previously known as pachydermoperiostosis) with a causal variant in the SLCO2A1 gene.
Journal: The British journal of dermatology
Published: December 18, 2025
Bioactive Multifunctional Hydrogel Scaffolds Remodel the Inflammatory Microenvironment and Osteogenic-Osteoclastic Homeostasis to Advance Osteoporotic Bone Defect Repair.
Journal: ACS nano
Published: December 15, 2025
Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome : A Systematic Review and Meta-analysis.
Journal: Annals of internal medicine
Published: December 15, 2025
Proton Pump Inhibitors Are Associated With Increased Risk of Site-Specific Nonunion After Open Reduction Internal Fixation.
Journal: Journal of orthopaedic trauma
Published: December 09, 2025
Clinical and economic impact of deep learning-enhanced opportunistic osteoporosis screening using chest radiographs with and without the osteoporosis self-assessment tool for Asians (OSTA).
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: December 05, 2025
Engineered 3D Printing Bilayer Scaffold with Spatiotemporal Release of Drug for Synergistic Osteochondral Regeneration.
Journal: Advanced healthcare materials
Published: December 03, 2025
The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.
Journal: Expert opinion on drug discovery
Published: November 24, 2025
Comment on real-world persistence and interpretation of BMD outcomes in denosumab vs. alendronate therapy.
Journal: Journal of bone and mineral metabolism
Published: November 23, 2025
Knowledge and Adherence to Alendronate Administration Among Postmenopausal Osteoporosis Patients: A Cross-Sectional Study From a Tertiary Care Facility in Colombo South.
Journal: Cureus
Published: November 14, 2025
Last Updated: 02/24/2026